NO881613L - Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklisk-alifatiske karboksamider. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklisk-alifatiske karboksamider.Info
- Publication number
- NO881613L NO881613L NO881613A NO881613A NO881613L NO 881613 L NO881613 L NO 881613L NO 881613 A NO881613 A NO 881613A NO 881613 A NO881613 A NO 881613A NO 881613 L NO881613 L NO 881613L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- therapeutic active
- active heterocyclic
- aliphatic carboxamides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3885387A | 1987-04-15 | 1987-04-15 | |
US10349087A | 1987-10-01 | 1987-10-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO881613D0 NO881613D0 (no) | 1988-04-14 |
NO881613L true NO881613L (no) | 1988-10-17 |
Family
ID=26715590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO881613A NO881613L (no) | 1987-04-15 | 1988-04-14 | Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklisk-alifatiske karboksamider. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0290145B1 (de) |
JP (1) | JP2553141B2 (de) |
KR (1) | KR880012548A (de) |
CN (1) | CN1030910A (de) |
AU (1) | AU600813B2 (de) |
CA (1) | CA1332835C (de) |
DE (1) | DE3851907T2 (de) |
DK (1) | DK208288A (de) |
FI (1) | FI881747A (de) |
HU (1) | HU204509B (de) |
IE (1) | IE65569B1 (de) |
IL (1) | IL86025A (de) |
MY (1) | MY103259A (de) |
NO (1) | NO881613L (de) |
NZ (1) | NZ224240A (de) |
PT (1) | PT87243B (de) |
ZW (1) | ZW3788A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8927981D0 (en) * | 1989-12-11 | 1990-02-14 | Ici Plc | Carbamoyl derivative |
US5286740A (en) * | 1989-12-11 | 1994-02-15 | Imperial Chemical Industries Plc | Carbamoyl derivatives |
US5281593A (en) * | 1990-07-31 | 1994-01-25 | Lilly Industries Limited | Certain indole derivatives useful as leukotriene antagonists |
AU654140B2 (en) * | 1990-07-31 | 1994-10-27 | Lilly Industries Limited | N-benzyl indoles, processes for their preparation or pharmaceutical compositions containing them |
CN1036101C (zh) * | 1990-11-24 | 1997-10-08 | 山东师范大学 | 一种开管铝镓扩散工艺 |
GB9119001D0 (en) * | 1991-09-05 | 1991-10-23 | Ici Plc | Pharmaceutical agents |
ATE122656T1 (de) * | 1991-10-25 | 1995-06-15 | Ciba Geigy Ag | Verfahren zur herstellung substituierter indole. |
ES2050611B1 (es) * | 1992-10-08 | 1994-12-16 | Ici Plc | Una nueva forma fisica de un derivado de carbamoilindol con propiedades antagonistas de leucotrienos. |
US5486612A (en) * | 1993-12-14 | 1996-01-23 | Eli Lilly And Company | N-benzyl dihydroindole LTD4 antagonists |
US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
GB2431927B (en) * | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
US8546431B2 (en) | 2008-10-01 | 2013-10-01 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
WO2013019682A1 (en) * | 2011-07-29 | 2013-02-07 | Tempero Pharmaceuticals, Inc. | Compounds and methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8426474D0 (en) * | 1984-10-19 | 1984-11-28 | Ici America Inc | Heterocyclic amides |
GB8524157D0 (en) * | 1984-10-19 | 1985-11-06 | Ici America Inc | Heterocyclic amides |
IL80336A (en) * | 1985-10-17 | 1990-02-09 | Ici America Inc | Indole or benzopyrazole derivatives,their preparation and pharmaceutical compositions containing them |
GB8707051D0 (en) * | 1986-04-15 | 1987-04-29 | Ici America Inc | Heterocyclic carboxamides |
-
1988
- 1988-04-07 MY MYPI88000354A patent/MY103259A/en unknown
- 1988-04-11 IE IE108688A patent/IE65569B1/en not_active IP Right Cessation
- 1988-04-11 HU HU881795A patent/HU204509B/hu not_active IP Right Cessation
- 1988-04-11 IL IL86025A patent/IL86025A/xx unknown
- 1988-04-11 AU AU14484/88A patent/AU600813B2/en not_active Ceased
- 1988-04-11 ZW ZW37/88A patent/ZW3788A1/xx unknown
- 1988-04-12 DE DE3851907T patent/DE3851907T2/de not_active Expired - Fee Related
- 1988-04-12 EP EP88303244A patent/EP0290145B1/de not_active Expired - Lifetime
- 1988-04-13 NZ NZ224240A patent/NZ224240A/en unknown
- 1988-04-14 NO NO881613A patent/NO881613L/no unknown
- 1988-04-14 FI FI881747A patent/FI881747A/fi not_active Application Discontinuation
- 1988-04-14 PT PT87243A patent/PT87243B/pt not_active IP Right Cessation
- 1988-04-15 DK DK208288A patent/DK208288A/da not_active Application Discontinuation
- 1988-04-15 KR KR1019880004352A patent/KR880012548A/ko not_active Application Discontinuation
- 1988-04-15 CA CA000564341A patent/CA1332835C/en not_active Expired - Fee Related
- 1988-04-15 CN CN88102361A patent/CN1030910A/zh active Pending
- 1988-04-15 JP JP63091898A patent/JP2553141B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL86025A0 (en) | 1989-01-31 |
JP2553141B2 (ja) | 1996-11-13 |
AU600813B2 (en) | 1990-08-23 |
PT87243B (pt) | 1992-08-31 |
HUT47246A (en) | 1989-02-28 |
NO881613D0 (no) | 1988-04-14 |
DK208288A (da) | 1988-10-16 |
DE3851907T2 (de) | 1995-06-01 |
KR880012548A (ko) | 1988-11-28 |
NZ224240A (en) | 1991-03-26 |
EP0290145A1 (de) | 1988-11-09 |
EP0290145B1 (de) | 1994-10-26 |
FI881747A (fi) | 1988-10-16 |
HU204509B (en) | 1992-01-28 |
IL86025A (en) | 1992-06-21 |
AU1448488A (en) | 1988-10-20 |
JPS63277660A (ja) | 1988-11-15 |
FI881747A0 (fi) | 1988-04-14 |
PT87243A (pt) | 1988-05-01 |
CA1332835C (en) | 1994-11-01 |
IE881086L (en) | 1988-10-15 |
MY103259A (en) | 1993-05-29 |
CN1030910A (zh) | 1989-02-08 |
DK208288D0 (da) | 1988-04-15 |
DE3851907D1 (de) | 1994-12-01 |
ZW3788A1 (en) | 1989-11-22 |
IE65569B1 (en) | 1995-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO883974D0 (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
NO875082D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer. | |
NO884154L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive preparater. | |
NO871277D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler. | |
NO871267L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser. | |
NO884473L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler. | |
NO874869D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
NO902411D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. | |
NO884052L (no) | Fremgangsmaate for fremstilling av terapeutisk preparat. | |
NO871588L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider. | |
NO883750L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. | |
NO883485D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser. | |
NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
NO881613D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklisk-alifatiske karboksamider. | |
NO167797C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt nitrometan. | |
NO890155L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. | |
NO880667L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser. | |
NO881762D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater. | |
NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
NO881884L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater. | |
NO168247C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner. | |
NO882281D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
NO892871D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
NO883959L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere. | |
NO882282L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. |